Thanks for the advice.
I’m happy with my understanding of biotech. There are many many many bio’s, with supposed high caliber management and boards who never succeed. And it’s not for the lack of knowledge.
Back to that patient. They had a stem cell transplant in addition to CHM treatment. I’ll put their response in the bin and focus on the other patients responses. Underwhelming, imv.
All the best.
- Forums
- ASX - By Stock
- Ann: CORE NK Platform Phase 1 Clinical Data Presentation
Thanks for the advice.I’m happy with my understanding of...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CHM (ASX) Chart |
Day chart unavailable